ANL
Adlai Nortye Ltd. American Depositary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$528.66M
P/E Ratio
—
EPS
$-1.14
Beta
-0.71
52W High
$12.09
52W Low
$0.88
50-Day MA
$8.20
200-Day MA
$3.23
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Adlai Nortye Ltd. American Depositary Shares
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. The company is headquartered in Grand Cayman, the Cayman Islands.
Fundamentals
| Revenue (TTM) | $1.94M |
| Gross Profit (TTM) | $1.94M |
| EBITDA | $-41.88M |
| Operating Margin | 0.00% |
| Return on Equity | -139.00% |
| Return on Assets | -29.80% |
| Revenue/Share (TTM) | $0.06 |
| Book Value | $0.21 |
| Price-to-Book | 60.81 |
| Price-to-Sales (TTM) | 15.50 |
| EV/Revenue | 3.806 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 118.00% |
| Shares Outstanding | $53.08M |
| Float | $57.08M |
| % Insiders | 5.08% |
| % Institutions | 6.19% |
Analyst Ratings
Consensus ($28.33 target)
2
BuyData last updated: 4/7/2026